دواعي استعمال تانفابيت مرهم 30 جم

Topical ointment combining betamethasone and calcipotriol for psoriasis, 30 g, marketed in Egypt by Al Esraa Pharmaceutical Optima.

• Topical treatment of plaque psoriasis in patients 12 years of age and older.DailyMed (US National Library of Medicine)

• Most common (>= 1%): pruritus and scaly rash.نشرة دولية لتركيبة مكافئة · DailyMed (US National Library of Medicine)

• None (US label).نشرة دولية لتركيبة مكافئة · DailyMed (US National Library of Medicine)

• Hypercalcaemia and hypercalciuria have been observed; stop treatment until calcium parameters normalise.نشرة دولية لتركيبة مكافئة · DailyMed (US National Library of Medicine)
• Can produce reversible HPA-axis suppression (adrenal suppression in 5 of 32 subjects after 4 weeks in one trial); risk rises with large areas, occlusion, prolonged use, multiple corticosteroids, altered skin barrier, liver failure and children.نشرة دولية لتركيبة مكافئة · DailyMed (US National Library of Medicine)
• May increase the risk of cataract and glaucoma; allergic contact dermatitis to either component; discontinue if irritation develops; limit UV light exposure.نشرة دولية لتركيبة مكافئة · DailyMed (US National Library of Medicine)

• Limited data are insufficient to evaluate risk; observational studies suggest increased risk of low birthweight with maternal use of potent or very potent topical corticosteroids.نشرة دولية لتركيبة مكافئة · DailyMed (US National Library of Medicine)
• No information on presence in human milk; weigh benefits of breastfeeding against maternal need; use on the smallest area for the shortest duration while breastfeeding and do not apply directly to the nipple and areola.نشرة دولية لتركيبة مكافئة · DailyMed (US National Library of Medicine)

• Consider evaluation for HPA-axis suppression (cosyntropin stimulation test) in at-risk patients; monitor calcium if hypercalcaemia is suspected.نشرة دولية لتركيبة مكافئة · DailyMed (US National Library of Medicine)